When and How to Incorporate Steroids for Persistent Diabetic Macular Edema: A Discussion of Real-World Treatment Optimization Strategies

Ophthalmic Surgery, Lasers & Imaging Retina
David A EichenbaumVeeral S Sheth

Abstract

In the United States, diabetic macular edema (DME) is the leading cause of vision loss among people with diabetic retinopathy. Despite the availability of different therapies for DME, up to half of patients with DME show some persistent edema after anti-vascular endothelial growth factor (VEGF) treatment alone, leaving these patients at high risk for vision loss. However, dosing in a similar fashion to that of pivotal anti-VEGF trials is difficult because of real-life challenges faced in clinical practice. This is particularly true for DME, in that the frequency and burden of anti-VEGF injections are a major challenge to patient care. Research evaluating anti-VEGF therapies has shaped the treatment paradigms for patients with DME, and similar benefits have also been noted in clinical trials evaluating the use of intravitreal steroids. Treatment with a long-term intravitreal corticosteroid, which requires fewer injections than treatment with most short-acting therapies, has been found to reduce inflammation and improve vision in a percentage of patients. This roundtable discussion, which took place during the 2018 annual meeting of the Vit-Buckle Society, reviews the current treatment paradigms for DME and evaluates how to custo...Continue Reading

References

Nov 3, 2004·Journal of Cataract and Refractive Surgery·H Burkhard DickShakhsanam Aliyeva
Feb 10, 2010·Middle East African Journal of Ophthalmology·John P Berdahl
Apr 5, 2011·Ophthalmology·Peter A CampochiaroUNKNOWN FAME Study Group
Sep 5, 2012·Indian Journal of Ophthalmology·João M FurtadoBruce Spivey
Jan 1, 2014·World Journal of Diabetes·J Fernando Arevalo
Feb 19, 2015·The New England Journal of Medicine·UNKNOWN Diabetic Retinopathy Clinical Research NetworkRoy W Beck
Jul 3, 2015·Journal of Diabetes Research·F SemeraroC Costagliola
Jul 15, 2015·The Cochrane Database of Systematic Reviews·Mingjuan Lisa ZhangHenry Jampel
Nov 26, 2015·Eye and Vision·Ryan LeeCharumathi Sabanayagam
Jun 16, 2016·F1000Research·Michael A SingerLyndon Tyler
Oct 21, 2016·Journal of Diabetes Research·Pedro Romero-ArocaRaquel Verges

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.